Welcome to the ZHAO Qi Team


The Zhao Qi Research Group is a multidisciplinary bioinformatics team based at Sun Yat-sen university Cancer Center, dedicated to advancing research in gastrointestinal (GI) cancers.
Our work integrates computational biology, machine learning, and multi-omics analysis to uncover molecular mechanisms of cancer, identify clinically actionable biomarkers, and support precision oncology.

Our research spans several interconnected areas:

Cancer Immunotherapy Biomarkers

Mining multi-omics data to spot biomarkers that flag immunotherapy responders, then packaging those signals into clinical assays for patient selection and combo dosing.

Cancer Genomics Software & Databases

Shipping open-source algorithms, containerized workflows and curated databases that let the community reproduce and extend large-scale cancer genomics studies.

Targeted Therapy Strategies for GI Cancers

Scanning exome, transcriptome and drug-screen datasets to surface druggable lesions in GI tumors, mapping trials to the right inhibitors and tracing resistance with real-time liquid biopsies.

Machine Learning for Cancer Diagnosis & Prognosis

Training lightweight models on pathology images, radiology scans and routine labs to flag early-stage tumors, forecast survival and explain calls in clinician-friendly heat-maps.

Gut Microbiota & Tumor Microenvironment

Tracking gut-bug shifts during ICI treatment, testing causality in germ-free models and crafting next-gen probiotics that sharpen anti-tumor immunity.

Latest News

Our New ecDNA Allocation Algorithm GCAP Launches
Our New ecDNA Allocation Algorithm GCAP Launches

Our new ecDNA allocation algorithm GCAP is now live! linc. Congratulations to Shixiang Wang! GCAP enables determination of ecDNA status from whole-exome sequencing (WES) datasets. Using GCAP, we further reveal that ecDNA may serve as a promising biomarker for ICI treatment in gastrointestinal (GI) cancers.

Latest Preprints